Morton Brown Family Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15K Hold
79
﹤0.01% 177
2026
Q1
$13.3K Hold
79
﹤0.01% 176
2025
Q4
$13.3K Hold
79
﹤0.01% 175
2025
Q3
$11.4K Hold
79
﹤0.01% 179
2025
Q2
$9.98K Hold
79
﹤0.01% 191
2025
Q1
$10.1K Hold
79
﹤0.01% 190
2024
Q4
$10.4K Hold
79
﹤0.01% 174
2024
Q3
$11.5K Hold
79
﹤0.01% 161
2024
Q2
$11.3K Hold
79
﹤0.01% 149
2024
Q1
$10.8K Hold
79
﹤0.01% 148
2023
Q4
$10.7K Buy
79
+1
+1% +$122 ﹤0.01% 179
2023
Q3
$9.59K Hold
78
﹤0.01% 125
2023
Q2
$9.95K Hold
78
0.01% 119
2023
Q1
$10.1K Hold
78
0.01% 129
2022
Q4
$10.3K Hold
78
0.01% 112
2022
Q3
$9K Hold
78
0.01% 115
2022
Q2
$9K Hold
78
0.01% 114
2022
Q1
$10K Hold
78
0.01% 107
2021
Q4
$12K Buy
+78
New +$12.1K 0.01% 116

Other funds holding IBB

Morton Brown Family Wealth's IBB Position: Q2 2026 in Review

Morton Brown Family Wealth held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 79 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #177.

Morton Brown Family Wealth first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Morton Brown Family Wealth held 79 shares of iShares Biotechnology ETF worth $15K as of Q2 2026.
  • Morton Brown Family Wealth left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Morton Brown Family Wealth's portfolio in Q2 2026, its #177 holding.
  • Morton Brown Family Wealth first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Morton Brown Family Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.